1. Home
  2. DAKT vs INM Comparison

DAKT vs INM Comparison

Compare DAKT & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$18.54

Market Cap

872.1M

Sector

Industrials

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.22

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
INM
Founded
1968
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.1M
3.7M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
DAKT
INM
Price
$18.54
$1.22
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$26.00
N/A
AVG Volume (30 Days)
515.8K
137.3K
Earning Date
12-10-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$770,283,000.00
$4,798,116.00
Revenue This Year
$13.76
N/A
Revenue Next Year
$7.35
N/A
P/E Ratio
$126.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.24
$1.13
52 Week High
$24.38
$8.27

Technical Indicators

Market Signals
Indicator
DAKT
INM
Relative Strength Index (RSI) 46.98 40.93
Support Level $18.16 $1.18
Resistance Level $19.08 $1.35
Average True Range (ATR) 0.87 0.10
MACD -0.02 0.01
Stochastic Oscillator 23.92 17.19

Price Performance

Historical Comparison
DAKT
INM

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: